Hims & Hers stock rebounded sharply from below $14 after regulatory challenges, now trading above $37 driven by robust monthly weight-loss subscriber additions exceeding 100,000. The company leverages GLP-1 products as a key customer acquisition tool, while expanding into peptides, AI healthcare systems, and international markets, creating multiple growth opportunities beyond traditional telehealth and pharmacy models. Elevated short interest near 30% could boost gains if earnings and subscriber momentum continue to accelerate.

More News (HIMS)

Amplify Online Retail ETF surges on strong gains in digital healthcare and travel stocks in June

The Amplify Online Retail ETF (IBUY) saw a significant rally in June, driven by strong performance in digital healthcare, specialized e-commerce, and online travel stocks. Key contributors included Hims & Hers Health, Wayfair, Tripadvisor, Instacart,...

Market News

Bullish

1 day ago

Hims & Hers stock surges above $37 on strong subscriber growth and diversified healthcare expansion

More News (HIMS)

Amplify Online Retail ETF surges on strong gains in digital healthcare and travel stocks in June

Invest & Trade with
#1 Award-Winning Investment Super App

Invest

Features

Fees

Learn

Investment Clubs (Coming Soon)

Support

iOS App Store

Google Play Store

Hims & Hers stock surges above $37 on strong subscriber growth and diversified healthcare expansion

More News (HIMS)

Amplify Online Retail ETF surges on strong gains in digital healthcare and travel stocks in June

Invest & Trade with#1 Award-Winning Investment Super App

iOS App Store

Google Play Store

Invest & Trade with
#1 Award-Winning Investment Super App